• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Aproteasome-p27 system is involved in growth inhibition by PPARγ ligands in GI cancers

Research Project

Project/Area Number 14570438
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionAsahikawa Medical College

Principal Investigator

OKUMURA Toshikatsu  Asahikawa Medical College, Department of General Medicine, Professor, 医学部, 教授 (60281903)

Co-Investigator(Kenkyū-buntansha) TANNO Satoshi  Asahikawa Medical College, Department of General Medicine, Assistant Professor, 医学部, 講師 (30333686)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2002: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordstroglitazone / cancer / p27Kip1 / proteasome / skp2 / PPARgamma / PPARgamma / 胃癌 / プロテアソーム / 細胞増殖抑制 / 分
Research Abstract

We have demonstrated that peroxisome proliferator activated receptor gamma(PPARr) ligands inhibit cell growth in gastric and pancreatic cancer cells and that p27 accumulation is essential for the growth inhibition by PPAR ligands(Takahashi et al., FEBS Lett 1999,Motomura et al., Cancer Res 2000). In the present study, we tried to clarify the precise mechanisms by which PPAR ligand stimulates the protein expression of p27. Troglitazone, a ligand for PPAR, increased the protein amount of p27 and inhibited cell growth in gastric, pancreatic and hepatic cancer cells. Lactacystin, an proteasome inhibitor, by itself similarly inhibited cell growth and increased p27 protein expression. Troglitazone potently inhibited proteasome activity. These results suggest that PPAR activation by troglitazone inhibits proteasome activity, thereby accumulating p27 protein, which in turn inhibits cell growth. We furthermore demonstrated that troglitazone suppressed skp2, an ubiqutin ligaze, expression. All these results suggest that the growth inhibition by PPAR actibvation was mediated by p27^<Kip1> accumulation which is induced by both inhibition of ubiquitylation of p27^<Kip1> and reduction of degradation activity of p27^<Kip1> by proteasome.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Takeuchi S: "Troglitazone induces G1 arrest by p27Kip1 induction that is mediated by inhibition of proteasome in human gastric cancer cells"Jpn J Cancer Res. 93. 774-782 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nagamine M: "PPARr ligand-induced apoptosis through a p53 dependent mechanism in human gastric cancer cell"Cancer Sci. 94. 338-343 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Motomura W: "Growth arrest by troglitazone is mediated by p27^<Kip1> accumulation which is resulted from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells"Int J Cancer. 108. 41-46 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Motomura W: "Inhibition of cell invasion and morphological change by troglitazone in cultured human pancreatic cancer cells"J Gastroenterol. (in press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeuchi S: "Troglitazone induces G1 arrest by p27Kip1 induction that is mediated by inhibition of proteasome in human gastric cancer cells."Jpn J Cancer Res. 93. 774-782 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nagamine M: "PPARr ligand-induced apoptosis through a p53 dependent mechanism in human gastric cancer cell."Cancer Sci. 94. 338-343 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Motomura W: "Growth arrest by troglitazone is mediated by p27^<Kip1> accumulation which is resulted from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells."Int J Cancer. 108. 41-46 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Motomura W: "Inhibition of cell invasion and morphological change by troglitazone in cultured human pancreatic cancer cells."J Gastroenterol. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeuchi S: "Troglitazone induces G1 arrest by p27Kip1 induction that is mediated by inhibition of proteasome in human gastric cancer cells"Jpn J Cancer Res. 93. 774-782 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nagamine M: "PPARr ligand-induced apoptosis through a p53 dependent mechanism in human gastric cancer cell"Cancer Sci. 94. 338-343 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Motomura W: "Growth arrest by troglitazone is mediated by p27^<Kip1> accumulation which is resulted from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells"Int J Cancer. 108. 41-46 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Motomura W: "Inhibition of cell invasion and morphological change by troglitazone in cultured human pancreatic cancer cells"J Gastroenterol. (in press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takeuchi et al.: "Troglitazone induces G1 arrest by p27Kip1 induction that is mediated by inhibition of proteasome in human gastric cancer cells"Japanese Journal of Cancer Research. 93. 774-782 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nagamine et al.: "PPARr ligand-induced apoptosis through a p53 dependent mechanism in human gastric cancer cell"Cancer Sci. (in press). (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi